ChengDa Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020
Market Capitalization	6,687	3,057	3,934	4,912	-	-
Market Cap Growth	138.39%	-22.31%	-19.91%	-	-	-
Enterprise Value	5,765	1,875	2,523	3,463	-	-
Last Close Price	44.15	20.00	24.93	30.90	-	-
PE Ratio	-	-	43.24	46.13	-	-
PS Ratio	17.86	9.18	9.50	11.94	-	-
PB Ratio	3.14	1.43	1.73	2.22	-	-
P/TBV Ratio	3.19	1.45	1.75	2.25	-	-
P/OCF Ratio	179.83	106.70	20.48	103.06	-	-
EV/Sales Ratio	15.40	5.63	6.09	8.42	-	-
EV/EBITDA Ratio	-	-	25.67	32.80	-	-
EV/EBIT Ratio	-	-	43.75	49.28	-	-
Debt / Equity Ratio	0.03	0.04	-	-	0.13	0.02
Debt / EBITDA Ratio	-	-	-	-	0.48	0.08
Debt / FCF Ratio	-	-	-	-	-	0.15
Net Debt / Equity Ratio	-0.43	-0.49	-0.60	-0.62	0.10	-0.08
Net Debt / EBITDA Ratio	38.18	45.49	-13.88	-13.08	0.36	-0.29
Net Debt / FCF Ratio	5.30	4.10	41.84	8.74	-0.91	-0.57
Asset Turnover	0.16	0.14	0.17	0.27	0.68	0.69
Inventory Turnover	1.60	1.56	1.67	1.75	2.66	3.11
Quick Ratio	6.23	5.97	8.69	14.99	0.76	1.59
Current Ratio	7.38	6.84	9.58	16.88	1.53	2.49
Return on Equity (ROE)	-2.35%	-1.25%	4.05%	7.75%	20.28%	29.31%
Return on Assets (ROA)	-1.99%	-1.79%	1.51%	2.92%	11.51%	11.79%
Return on Invested Capital (ROIC)	-6.44%	-6.72%	5.76%	8.80%	19.45%	20.95%
Return on Capital Employed (ROCE)	-3.50%	-3.10%	2.50%	3.20%	20.90%	21.90%
Earnings Yield	-0.77%	-0.92%	2.31%	2.17%	-	-
FCF Yield	-2.61%	-8.43%	-0.83%	-3.22%	-	-
Dividend Yield	0.46%	1.00%	0.80%	0.61%	-	-
Payout Ratio	-	-	31.89%	41.12%	31.20%	18.85%
Buyback Yield / Dilution	0.87%	1.75%	-2.12%	-30.56%	0.00%	-9.67%
Total Shareholder Return	1.33%	2.75%	-1.32%	-29.96%	0.00%	-9.67%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.